• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
pivot change turnaround direction walk away
Pharma

Roche's Gazyva secures FDA nod in 2nd autoimmune indication

Gazyva won FDA approval to reduce relapse risk in patients 2 and older with frequently relapsing or steroid-dependent childhood-onset INS.
Donavyn Coffey Sep 28, 2026 2:29pm
BioNTech

BioNTech to close sites in Germany after failed sale

Sep 28, 2026 10:59am
Its a Jungle Out There Hiring for Resilience in Life Sciences Sales

Hiring for Resilience in Life Sciences Sales

Brought to you by Mix Talent
population health representation

Lilly to expand global GLP-1 access by 2040

Sep 28, 2026 9:59am
AbbVie

AbbVie notches FDA nod for Ceverel asset Juvmo in Parkinson's

Sep 28, 2026 8:15am
Merck Debbie Allen

Merck welcomes Debbie Allen into holistic HIV health hive

Sep 28, 2026 2:00am
More News

Mirum scores FDA approval for ultra-rare disorder

Sep 25, 2026 4:10pm

The Oral GLP-1 Tracker: Scripts bounce back from holiday lull

Sep 25, 2026 2:00pm

Merck’s Welireg combo nabs FDA nod to expand kidney cancer reach

Sep 25, 2026 11:30am

Lundbeck relocating US headquarters to Boston in innovation move

Sep 25, 2026 10:41am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings